Taru Muranen's Biography

Taru Muranen, Assistant Professor of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School

Dr. Muranen’s lab focuses on studying how tumor stroma, and more specifically extracellular matrix proteins contribute to tumor growth and drug resistance in breast and pancreatic cancers. Dr. Muranen got her PhD in the University of Helsinki, Finland, completed her postdoctoral training at Harvard Medical School with Dr. Joan Brugge, and started her own laboratory in Beth Israel Deaconess Medical Center in late 2016.

Novel Organoid Models for the Study of Hormone Positive Breast Cancer

Tuesday, 22 March 2022 at 14:30

Add to Calendar ▼2022-03-22 14:30:002022-03-22 15:30:00Europe/LondonNovel Organoid Models for the Study of Hormone Positive Breast CancerClinical Translation of Organoids and Organs-on-Chips 2022 in BostonBostonSELECTBIOenquiries@selectbiosciences.com

We have been developing novel co-culture models of primary patient-derived tumor organoids with matching primary cancer-associated fibroblasts to investigate tumor-stroma crosstalk in hormone receptor positive breast cancer.

Add to Calendar ▼2022-03-21 00:00:002022-03-22 00:00:00Europe/LondonClinical Translation of Organoids and Organs-on-Chips 2022Clinical Translation of Organoids and Organs-on-Chips 2022 in BostonBostonSELECTBIOenquiries@selectbiosciences.com

Conference Sponsors